Copyright
©The Author(s) 2023.
World J Clin Oncol. Feb 24, 2023; 14(2): 89-98
Published online Feb 24, 2023. doi: 10.5306/wjco.v14.i2.89
Published online Feb 24, 2023. doi: 10.5306/wjco.v14.i2.89
Table 2 American Joint Committee on Cancer classification and staging for soft tissue sarcoma, 8th Edition
| TNM classification | Stage |
| T1: Tumor ≤ 5 cm | IA: T1; N0; M0; G1 |
| T2: Tumor > 5 cm and ≤ 10 cm | IB: T2, T3, T4; N0; M0; G1 |
| T3: Tumor > 10 cm and ≤ 15 cm | II: T1; N0; M0; G2/3 |
| T4: Tumor > 15 cm | IIIA: T2; N0; M0; G2/3 |
| N0: No regional lymph node metastasis or unknown lymph node status | IIIB: T3, T4; N0; M0; G2/3 |
| N1: Regional lymph node metastasis | IV: Any T; N1; M0; any G Any T; any N; M1; any G |
| M0: No distant metastasis | |
| M1: Distant metastasis |
- Citation: Pavlidis ET, Pavlidis TE. New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy. World J Clin Oncol 2023; 14(2): 89-98
- URL: https://www.wjgnet.com/2218-4333/full/v14/i2/89.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i2.89